adMare
News
May 13 2026
VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform
April 30 2026
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
April 16 2026
adMare BioInnovations Officially Opens M4 Innovation Centre in Vancouver to Support the Growth of Life Sciences Companies in Canada
March 03 2026
New Canadian Biotech 26therapeutics Inc. Targets Root Cause of Dry Eye Disease with First-in-Class Therapy
January 27 2026
Ocythera Secures Seed Financing from adMare BioInnovations and Fonds Impulsion to Advance Therapies for Rare Bone Diseases
January 15 2026
adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases
January 09 2026
Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board
December 11 2025
adMare BioInnovations Launches Cohort VIII of the Executive Institute to Strengthen Leadership Driving Canadian Life Sciences Company Growth
November 24 2025
AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec
July 09 2025
New adMare Institute Report Examines Capital Flows in Canadian Life Sciences and the Urgent Need to Capture Domestic Economic Value
Newsletter
Stay up to date on the
latest adMare news
Vancouver Innovation Centre
2405 Wesbrook Mall
Vancouver, British Columbia, Canada
V6T 1Z3
T. 604.364.1220
Toronto Office
MaRS Centre Heritage Building
101 College Street, Suite 250
Toronto, Ontario, Canada
M5G 1L7
T. 416.673.8100
Montreal Innovation Centre
7171 Frederick-Banting
Montréal, Québec, Canada
H4S 1Z9
